TickerFactsScreenerDevelopers

Insight Molecular Diagnostics Inc. (IMDX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $101.0K2014: $257.0K2015: $8.00M2016: $10.17M2017: $7.60M2018: $8.03M2019: $22.07M2020: $7.14M2021: $32.95M2022: $19.99M2023: $9.43M2024: $8.64M2025: $11.58M$11.58M
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$11.58M+34.1%
2024$8.64M-8.4%
2023$9.43M-52.8%
2022$19.99M-39.3%
2021$32.95M+361.3%
2020$7.14M-67.6%
2019$22.07M+174.7%
2018$8.03M+5.7%
2017$7.60M-25.3%
2016$10.17M+27.2%
2015$8.00M+3011.3%
2014$257.0K+154.5%
2013$101.0K—